Stocks · Health care · Pharmaceutical Preparations

ZEVRA THERAPEUTICS, INC.

ZVRA Clue Score60
United States Fiscal year ends December CIK 0001434647 Results filed 3 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Corey Michael Watton
10 Aug 2026
Director
Sold after exercise
12,300
$11.25
$138.38K
Joshua Schafer
30 Jan 2026
CCO
Sold after exercise
3,375
$8.83
$29.80K
Adrian W Quartel
30 Jan 2026
Chief Medical Officer
Sold after exercise
4,533
$8.83
$40.04K
Rahsaan Thompson
30 Jan 2026
Chief Legal & Compliance
Sold after exercise
4,080
$8.83
$36.01K
Timothy J. Sangiovanni
30 Jan 2026
SVP, Finance & Corp Controller
Sold after exercise
1,750
$8.82
$15.44K
Neil F. McFarlane
10 Oct 2025
President and CEO
Sold after exercise
19,500
$10.82
$210.91K

What was left out

Form 4 filings counted 242
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 6
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 2,575,641
History held since 17 Apr 2015